Human breast milk is increasingly recognized not only as nourishment but as a dynamic medium of biological information-delivering nutrients, immune molecules, and microbial ecosystems critical to early development. While each mother transmits a unique immunological and microbiota profile, the developmental impact of amplifying this diversity remains unexplored. Here, we introduce the Vyarna Booster: a novel, shelf-stable powder formed by combining lyophilized breast milk from multiple verified providers to intentionally exceed the microbial diversity found in any single sample. Using 16S rRNA gene sequencing, we analyzed bacterial composition across fresh (F), individually lyophilized (L), and mixed composite (M) samples from 13 mothers. The composite formulation exhibited greater microbial richness and evenness than any source sample, with consistently elevated abundance of commensals such as Streptococcus salivarius and Lactococcus raffinolactis. This increased diversity was reproducible across independently assembled mixes. While we do not claim viability or clinical outcomes, the observed taxonomic amplification suggests a previously untested mechanism for engineering postnatal microbial exposure. We propose the Vyarna Booster as a new class of infant nutritional supplement-one that augments the natural limits of human milk through deliberate bioinformational combination, and raises foundational questions about the boundaries of maternal transmission, microbial design, and early life programming.
Streptococcus pneumoniae continues to be a leading pathogen responsible for severe respiratory related diseases among children, often demanding prolonged treatment with antibiotics. In this study, we developed a chitosan-modified PLGA/alginate nanoparticles for controlled doxycycline delivery (CS-PLGA/Alginate@Doxy NPs) with the goal of improving therapeutic effect while reducing dosing frequency and treatment-related difficulties. The fabricated NPs demonstrated a well-defined spherical structure with an average diameter close to 50-70 nm, a stable negative surface charge, and a notably high drug encapsulation capability, confirming their suitability for inhalation-based antimicrobial therapy. In vitro drug release studies confirmed sustained Doxy release over 72 hours under different pH conditions. Antibacterial activity was evaluated against of S. pneumoniae, showing significantly improved bactericidal activity compared to free Doxy and other combinations. Further, the crystal violet assay and fluorescent microscopy analysis reveals that, the S. pneumoniae biofilm thickness was significantly reduced with visible disintegration of EPS matrix when exposed to CS-PLGA/Alginate@Doxy NPs. Cytocompatibility assays on fibroblast (L929) and human lung epithelial cells (L-132) confirmed the safety profile of the CS-PLGA/Alginate@Doxy NPs for pediatric use. The results proposed that the fabricated CS-PLGA/Alginate@Doxy NPs signifies a promising targeted delivery platform for the effective management of pediatric pneumococcal infections.
Mannheimia haemolytica (Mh) is an opportunistic pathogen that causes pneumonic infections in different ruminants. It is also part of the respiratory tract microbiome, but it descends into the lower respiratory tract under stress, causing shipping fever. The stress hormones epinephrine and norepinephrine have been suggested to induce Mh biofilm dispersion, but their roles in virulence have not been shown. In this study, the effects of these two hormones on Mh growth and on the expression of adhesins, proteases, and biofilm formation are evaluated. Physiological concentrations (1-5 ng/mL) of epinephrine and norepinephrine increase the growth of Mh and the expression of 42- and 75-kDa gelatin proteases, induce biofilm dispersion, and decrease biofilm protein and carbohydrate concentrations. At 50 or 500 ng/mL concentrations of epinephrine and norepinephrine, the expression of OmpA and OmpH adhesins and 42- and 100-kDa casein proteases increases. Bacterial adhesion to bovine monocytes or oral epithelial cells also increases, but antibodies against OmpH and OmpA diminish adhesion. Our results strongly suggest that epinephrine and norepinephrine modulate the expression of Mh virulence factors.

